2022
DOI: 10.1166/jbn.2022.3315
|View full text |Cite
|
Sign up to set email alerts
|

Carrier-Free Nanomedicine for Cancer Immunotherapy

Abstract: With the rapid development of nanotechnology, carrier-based nano-drug delivery systems (DDSs) have been widely studied due to their advantages in optimizing pharmacokinetic and distribution profiles. However, despite those merits, some carrier-related limitations, such as low drug-loading capacity, systematic toxicity and unclear metabolism, usually prevent their further clinical transformation. Carrier-free nanomedicines with non-therapeutic excipients, are considered as an excellent paradigm to overcome the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 88 publications
0
4
0
Order By: Relevance
“…[132] They can be obtained using various preparation methods, but their usage must be optimized by considering their advantages, such as large surface area and high biocompatibility, and disadvantages, such as high preparation difficulty, low stability, and potential toxicity. [133] Li et al [104] developed a…”
Section: Carrier-free Nanomaterials Of Inducing Pyroptosismentioning
confidence: 99%
See 1 more Smart Citation
“…[132] They can be obtained using various preparation methods, but their usage must be optimized by considering their advantages, such as large surface area and high biocompatibility, and disadvantages, such as high preparation difficulty, low stability, and potential toxicity. [133] Li et al [104] developed a…”
Section: Carrier-free Nanomaterials Of Inducing Pyroptosismentioning
confidence: 99%
“…[ 132 ] They can be obtained using various preparation methods, but their usage must be optimized by considering their advantages, such as large surface area and high biocompatibility, and disadvantages, such as high preparation difficulty, low stability, and potential toxicity. [ 133 ] Li et al. [ 104 ] developed a chemo‐photodynamic nanoplatform(A‐C/NPs) that effectively induced GSDME‐mediated pyroptosis resulting in immunogenic cell death that released HMGB1, ATP, and CRT, showing potent antitumor effects in a breast cancer mouse model and effectively suppressing tumor growth.…”
Section: The Application Of Biomaterials Induced Pyroptosis In Cancer...mentioning
confidence: 99%
“…Therefore, developing reagents that can effectively eliminate tumors while alleviating cancer pain is crucial for improving patients’ quality of life . In recent years, tumor immunotherapy has been regarded as the most promising therapeutic strategy. Nevertheless, the inherent immunosuppressive microenvironment of the tumor greatly reduces the effectiveness of the immunotherapy. Therefore, the elimination of immunosuppressive factors is a critical method for immunotherapy. Transforming growth factor-β (TGF-β), as an immunosuppressive cytokine in the tumor microenvironment, has been shown to promote tumor immune escape and metastasis, making it a critical target for immunotherapy. Additionally, TGF-β also plays a pivotal role in tumor-induced hyperalgesia. Therefore, the efficient inhibition of TGF-β within the tumor extracellular matrix can mitigate tumor-induced immunosuppression and alleviate cancer-associated pain.…”
Section: Introductionmentioning
confidence: 99%
“…[8] Carrier-free nanodrugs with high drug-loading efficiency (50%-100%) have attracted interest in the research community. [9] Camptothecin and its analogs, which contain planar pentacyclic quinolones and have a high tendency to self-assemble into cylindrical aggregates in water. However, it is difficult to form stable nanoparticles (NPs) using single-free CPT.…”
Section: Introductionmentioning
confidence: 99%